Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease - Test2 - elhamkhani - TriplyDB

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

http://www.wikidata.org/entity/Q26825409

about

Bedside-to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria The association of the vanin-1 N131S variant with blood pressure is mediated by endoplasmic reticulum-associated degradation and loss of function.Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients.Beta-Blocker Use Is Associated with Higher Renal Tissue Oxygenation in Hypertensive Patients Suspected of Renal Artery Stenosis.Combination of β Adrenergic Receptor Block and Renin-Angiotensin System Inhibition Diminished the Angiotensin II-Induced Vasoconstriction and Increased Bradykinin-Induced Vasodilation in Hypertension.Nebivolol Effects on Nitric Oxide Levels, Blood Pressure, and Renal Function in Kidney Transplant Patients.

P2860

Q26797153-26F455F0-FDA3-4F3E-84D6-504AB7267144 Q34214778-09D330F9-3246-487C-BC1E-28562069E9DA Q36263056-2E3F870A-2579-4589-B42C-D2F8EBDC65EA Q36925395-F6644BD7-1B73-47B3-9F41-792DBF7E2592 Q41073089-BFABB5F9-5EA3-4A34-88F4-1BABB08860D5 Q44636397-CC352565-AACF-4F23-866C-C12FA3241EE5 Q47890626-5D528AD2-AF77-4ED4-A512-15F75015CD2F

P2860

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

http://www.wikidata.org/entity/Q26825409

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@ast

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@en

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@nl

type

label

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@ast

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@en

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@nl

prefLabel

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@ast

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@en

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@nl

P1433

Q26825409-6C2BE4B3-B9B3-4861-9558-89AF21075682

P1476

Q26825409-40F96B04-F917-4948-8BA5-89864DB79B6C

P2093

Q26825409-98841AF3-01E5-4C2E-815A-17D499698206

Q26825409-AF75133A-D3AF-4062-90EE-77778A55B6D5

P2860

Q26825409-18C38F3A-95F5-4729-A496-B523418A37EC

Q26825409-2147749A-67CC-4F3C-AE19-1E4DF28C5FB5

Q26825409-214E6C3F-FD2D-4D6F-ACCB-B2283061B155

Q26825409-23CE362D-A5FF-4A12-A728-D3B6F2B881E3

Q26825409-25FE2143-2230-4C91-BB70-3FA6FF86AED7

Q26825409-27275391-DB4D-472A-BF79-EC3811345E8D

Q26825409-37ABC94D-8EA3-4D18-941C-E763F9A9D79E

Q26825409-380F373F-04E1-4415-98D6-185A0583E585

Q26825409-42F111F9-DF1E-4767-80C3-A0D421122585

Q26825409-45669DE3-5E25-4A8F-8158-564F7D4A1116

P304

Q26825409-063DE620-3498-48C0-A877-BA68AD62EC66

P31

Q26825409-E73992FE-FDF0-4E73-883F-550FDD77F2E1

P356

Q26825409-374981BD-019F-40FB-936D-CC728C39CC90

P407

Q26825409-486F2AE1-C69D-4E9E-B04C-C8A1D1D6A171

P478

Q26825409-72C86A31-8A7C-489F-9A19-0D0334DB17A8

P577

Q26825409-6388CD3B-239E-49FA-8A4B-975B20938903

P5875

Q26825409-B04A812D-045C-44DC-89CE-9CA5C1D9393F

P698

Q26825409-8C93FE9A-E935-4BFE-A0F1-12B9EE1C4EAF

P921

Q26825409-F624C009-E919-4755-9BED-0FE18CDFC285

P932

Q26825409-62457A7B-7416-4A3F-A23F-FC198AE78720

P356

P1433

International Journal of Hypertension

P1476

Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease

@en

P2093

Akira Yamashina

http://www.w3.org/2001/XMLSchema#string

Hirofumi Tomiyama

http://www.w3.org/2001/XMLSchema#string

P2860

Beta-blockers for hypertension

Beta-blockers for hypertension

Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index

Acute myocardial infarction and renal dysfunction: a high-risk combination

Atenolol in hypertension: is it a wise choice?

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials.

Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.

P304

919256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/919256

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261141127

http://www.w3.org/2001/XMLSchema#string

P698

24672712

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

P932

3941231

http://www.w3.org/2001/XMLSchema#string